Activation of ERBB2 Signaling Causes Resistance to the EGFR-Directed Therapeutic Antibody CetuximabKimio Yonesaka, Pasi A. Jänne, Dalia Ercan et al.|Science Translational Medicine|2011Cited by 670
The lymphatic system controls intestinal inflammation and inflammation-associated colon cancer through the chemokine decoy receptor D6Stefania Vetrano, Silvio Danese, Elena Monica Borroni et al.|Gut|2009Cited by 154
365 The Lymphatic System Controls Intestinal Inflammation and Inflammation-Associated Colon Cancer Through the Chemokine Decoy Receptor D6Stefania Vetrano, Silvio Danese, Elena Monica Borroni et al.|Gastroenterology|2009Cited by 7